IL6 and familial pancreatic carcinoma: Currently, there is substantial evidence that the Notch signaling pathway regulates IL-6 levels in Graves’ ophthalmopathy, fibroblasts, endometriotic lesions and breast tumor cells of pancreatic cancer (140–143).